Gen-Probe is currently developing the APTIMA HPV Assay, targeting E6/E7 mRNA from 14 carcinogenic HPV genotypes. A prototype of this assay was evaluated recently in 536 women with histological ...

We (ACM, TF) analysed studies in which patients of both sexes were screened for anal cancer using DNA HRHPV, mRNA HPV, DNA HPV16 and/or p16 biomarkers. The analysis was performed in pairs, for ...

mRNA testing for high-risk types correlates better with severity of the lesion compared with HPV DNA testing, and E6/E7 mRNA detection seems to be a predictive marker to identify women at risk of ...

近日，宝创HPV E6/E7 mRNA 14种全分型检测获批上市，单管可对14种高危型HPV E6/E7 mRNA实现全分型检测。迪安诊断在ICL行业内率先开展HPV E6/E7 mRNA 14种全分型基因检测，致力有效鉴别HPV持续感染、精准识别宫颈高级别病变和癌变风险。 大部分妇女一生中都会发生HPV一过 ...

Some human papillomavirus (HPV) tests check for mRNA E6/E7. E6 and E7 are proteins present in types of HPV viruses that carry a high risk of cancer. A positive test result indicates that a person ...

本产品通过对人体宫颈脱落细胞样本中14种高危型HPV（16, 18, 31, 33, 35,39, 45, 51, 52, 56, 58, 59, 66, 68）E6/E7区mRNA进行定性检测。用于筛查宫颈细胞学检查为 ...

14 High-Risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), and SOX1 and PAX1 Methylation Real-time PCR Kit. Hybribio presented its successful experience in cervical cancer prevention ...

We show that: 1) the mRNA is translated into the desired fusion protein, 2) an antigen-specific adaptive immune response is elicited in vaccinated mice and in a human-relevant co-culture platform, 3) ...

The patented technology that is Mia by XytoTest® enables laboratories to detect Hr-HPV DNA and allows for risk stratification by detecting biomarkers mRNA E6/E7 from the seven HPV-types proven to be ...

The patented technology that is Mia by XytoTest® enables laboratories to detect Hr-HPV DNA and allows for risk stratification by detecting biomarkers mRNA E6/E7 from the seven HPV-types proven to be ...